HK Stock MarketDetailed Quotes

06669 ACOTEC-B

Watchlist
  • 5.640
  • -0.140-2.42%
Market Closed Jan 9 16:08 CST
1.77BMarket Cap50.36P/E (TTM)

About ACOTEC-B Company

Xianruida Medical Technology Holdings Co., Ltd. is a leading interventional medical device company in China. Our products mainly focus on interventional treatment of vascular diseases, involving drug-coated balloons (DCB), peripheral balloon dilatation catheters (PTA), etc. Currently, we have established a comprehensive product portfolio for five major treatment fields, including vascular surgery, cardiology, nephrology, neurology, and andrology. The company has a number of core intellectual property rights at home and abroad, helps medical workers provide better patient treatment plans with innovative products, and is committed to building a “made in China, world-leading” brand. Currently, our business covers China, Asia, Europe and other countries and regions.

Company Profile

Symbol06669
Company NameACOTEC-B
ISINKYG0096M1096
Listing DateAug 24, 2021
Issue Price23.80
Shares Offered68.63M share(s)
FoundedDec 3, 2020
Registered AddressCayman Islands
Chairmanjing li
Secretarychenlijingyi li
Audit InstitutionKPMG
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficePO Box 309, Ugland House Grand Cayman KY1-1104 Cayman Islands
Head Office and Principal Place of Business19th Floor, Golden Dragon Centre, 188 Des Voeux Road Central, Hong Kong
Fiscal Year Ends12-31
Employees615
MarketHong Kong motherboard
Phone(010)67872107
Fax(010)67866678
Emailir@acotec.cn
Websitehttp://www.acotec.cn
Business Xianruida Medical Technology Holdings Co., Ltd. is a Chinese interventional medical device company. The company focuses on interventional treatment of vascular diseases, involving drug-coated balloons (DCB), peripheral balloon dilatation catheters (PTA), etc. The company has established a product portfolio for five major treatment areas, including vascular surgery, cardiology, nephrology, neurology, and andrology. The company's business covers China, Asia, Europe and other countries and regions.

Company Executives

  • Name
  • Position
  • Salary
  • jing li
  • Chairman of the Board, CEOs, Executive Director, Remuneration Committee Members, Nomination Committee Members, Authorized Representative
  • --
  • Silvio Rudolf SCHAFFNER
  • Non-executive Directors
  • --
  • Arthur Crosswell BUTCHER
  • Non-executive Directors
  • --
  • June CHANG
  • Non-executive Directors, Audit Committee Members
  • --
  • yuqi wang
  • Independent Non-Executive Director, Remuneration Committee Chairman, Chairman of the Nomination Committee, Audit Committee Members
  • --
  • hong ni
  • Independent Non-Executive Director, Remuneration Committee Members, Nomination Committee Members
  • --
  • jianer pan
  • Independent Non-Executive Director, Chairman of the Audit Committee
  • --
  • Ulrich Reinhold SPECK
  • Chief Technology Officer
  • --
  • weijia li
  • Vice President of Clinical and Regulatory Affairs
  • --
  • chen li
  • Joint Company Secretary
  • --
  • jingyi li
  • Joint Company Secretary, Authorized Representative
  • --
Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday+0.69%